Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Johannesburg - Delayed Quote ZAc

Labat Africa Limited (LAB.JO)

Compare
8.00
0.00
(0.00%)
As of April 16 at 5:00:07 PM GMT+2. Market Open.
Loading Chart for LAB.JO
  • Previous Close 8.00
  • Open 7.00
  • Bid 7.00 x --
  • Ask 8.00 x --
  • Day's Range 7.00 - 8.00
  • 52 Week Range 0.07 - 13.00
  • Volume 629,750
  • Avg. Volume 758,046
  • Market Cap (intraday) 89.033M
  • Beta (5Y Monthly) 1.26
  • PE Ratio (TTM) --
  • EPS (TTM) -0.04
  • Earnings Date Feb 28, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date Sep 21, 1992
  • 1y Target Est --

Labat Africa Limited, an investment holding company, engages in the technology, logistics, and healthcare activities in South Africa. The company operates through Technology, Logistics, and Healthcare segments. It engages in the manufacture and distribution of integrated circuits, including micro electronic systems; transportation of coals and minerals for mines; and sale of medical cannabis and information technology products. The company was incorporated in 1986 and is based in Roodepoort, South Africa.

www.labat.co.za

43

Full Time Employees

May 31

Fiscal Year Ends

Recent News: LAB.JO

View More

Performance Overview: LAB.JO

Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is All Share Index (^J203.JO) .

YTD Return

LAB.JO
14.29%
All Share Index (^J203.JO)
6.33%

1-Year Return

LAB.JO
11,328.57%
All Share Index (^J203.JO)
22.50%

3-Year Return

LAB.JO
3,536.36%
All Share Index (^J203.JO)
21.86%

5-Year Return

LAB.JO
1,951.28%
All Share Index (^J203.JO)
81.99%

Compare To: LAB.JO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LAB.JO

View More

Valuation Measures

Annual
As of 4/16/2025
  • Market Cap

    89.03M

  • Enterprise Value

    97.72M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.16

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    2.16

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -50.95%

  • Return on Assets (ttm)

    -12.52%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    45.18M

  • Net Income Avi to Common (ttm)

    -23.02M

  • Diluted EPS (ttm)

    -0.04

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    3.34M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -649.5k

Research Analysis: LAB.JO

View More

Company Insights: LAB.JO

Research Reports: LAB.JO

View More

People Also Watch